{"version":1,"type":"rich","provider_name":"Libsyn","provider_url":"https:\/\/www.libsyn.com","height":90,"width":600,"title":"JAMA: 2013-01-16, Vol. 309, No. 3, Author in the Room\u2122 Audio Interview","description":"Interview with Daniel S. Chertow, MD, MPH, author of Bacterial Coinfection in Influenza: A Grand Rounds Review. Summary Points:\n\nInfluenza vaccine remains the best available tool for prevention of severe influenza illness commonly associated with bacterial coinfection.\nEarly empirical antiviral and antibiotic therapy should be administered to all individuals with suspected coinfection.\nVancomycin or linezolid should be administered in addition to standard therapy for community-acquired pneumonia to patients with severe or necrotizing pneumonia and\/or evidence of sepsis.\n","author_name":"Author in the Room\u2122 Interviews","author_url":"http:\/\/jamanetwork.com\/index.aspx","html":"<iframe title=\"Libsyn Player\" style=\"border: none\" src=\"\/\/html5-player.libsyn.com\/embed\/episode\/id\/2228432\/height\/90\/theme\/custom\/thumbnail\/yes\/direction\/forward\/render-playlist\/no\/custom-color\/d71635\/\" height=\"90\" width=\"600\" scrolling=\"no\"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen><\/iframe>","thumbnail_url":"https:\/\/assets.libsyn.com\/secure\/content\/5425706"}